Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2011

Open Access 01-12-2011 | Case report

Pheochromocytoma presenting with arterial and intracardiac thrombus in a 47-year-old woman: a case report

Authors: Runhua Hou, Ann M Leathersich, Brenda Temke Ruud

Published in: Journal of Medical Case Reports | Issue 1/2011

Login to get access

Abstract

Introduction

Pheochromocytoma is a rare cause of hypertension but it could have severe consequences if not recognized and treated appropriately. The association of pheochromocytoma and thrombosis is even rarer but significantly increases management complexity, morbidity and mortality. To the best of our knowledge, this is the first report of a patient with pheochromocytoma presenting with left axillary arterial and intracardiac thrombus.

Case presentation

A 47-year-old Caucasian woman with a past medical history of hypertension presented for medical attention with left arm numbness. Doppler ultrasound showed an obstructing thrombus in her left axillary artery. She had symptom resolution after stent placement in her left axillary artery. A subsequent echocardiogram demonstrated a large intracardiac mass and abdominal computed tomography revealed a 7 cm mass between her spleen and left kidney. Labile blood pressure was noted during admission and she had very high levels of plasma and 24-hour urine catecholamines and metanephrines tests. A (123)I- metaiodobenzylguanidine scan showed intense uptake in the left abdominal mass. After adequate alpha blockage with phenoxybenzamine, laparoscopic tumor resection was performed without complications. She had normal metanephrines and complete symptom resolution afterwards. The intracardiac mass also disappeared with anticoagulation. All other endocrine laboratory abnormalities returned to normal after surgery.

Conclusion

Arterial and ventricular thrombosis occurring in patients with pheochromocytoma is rare. A multi-disciplinary approach is necessary in caring for this type of patient. Catecholamines likely contributed to the development of thrombosis in our patient. Early recognition of pheochromocytoma is the key to improving outcome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001, 134 (4): 315-329.CrossRefPubMed Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001, 134 (4): 315-329.CrossRefPubMed
2.
go back to reference Stein PP, Black HR: A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine. 1991, 70 (1): 46-66.CrossRefPubMed Stein PP, Black HR: A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine. 1991, 70 (1): 46-66.CrossRefPubMed
3.
go back to reference Heindel SW, Maslow AD, Steriti J, Mashikian JS: A patient with intracardiac masses and an undiagnosed pheochromocytoma. J Cardiothorac Vasc Anesth. 2002, 16 (3): 338-343. 10.1053/jcan.2002.124144.CrossRefPubMed Heindel SW, Maslow AD, Steriti J, Mashikian JS: A patient with intracardiac masses and an undiagnosed pheochromocytoma. J Cardiothorac Vasc Anesth. 2002, 16 (3): 338-343. 10.1053/jcan.2002.124144.CrossRefPubMed
4.
5.
go back to reference Shulkin BL, Shapiro B, Sisson JC: Pheochromocytoma, polycythemia, and venous thrombosis. Am J Med. 1987, 83 (4): 773-776. 10.1016/0002-9343(87)90913-2.CrossRefPubMed Shulkin BL, Shapiro B, Sisson JC: Pheochromocytoma, polycythemia, and venous thrombosis. Am J Med. 1987, 83 (4): 773-776. 10.1016/0002-9343(87)90913-2.CrossRefPubMed
6.
go back to reference Stella P, Bignotti G, Zerbi S, Ciurlino D, Landoni C, Fazio F, Bianchi G: Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis--a possible unique pathophysiological mechanism. Nephrol Dial Transplant. 2000, 15 (5): 717-718. 10.1093/ndt/15.5.717.CrossRefPubMed Stella P, Bignotti G, Zerbi S, Ciurlino D, Landoni C, Fazio F, Bianchi G: Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis--a possible unique pathophysiological mechanism. Nephrol Dial Transplant. 2000, 15 (5): 717-718. 10.1093/ndt/15.5.717.CrossRefPubMed
7.
go back to reference Stevenson S, Ramani V, Nasim A: Extra-adrenal pheochromocytoma: an unusual cause of deep vein thrombosis. J Vasc Surg. 2005, 42 (3): 570-572. 10.1016/j.jvs.2005.05.013.CrossRefPubMed Stevenson S, Ramani V, Nasim A: Extra-adrenal pheochromocytoma: an unusual cause of deep vein thrombosis. J Vasc Surg. 2005, 42 (3): 570-572. 10.1016/j.jvs.2005.05.013.CrossRefPubMed
8.
go back to reference Zhou W, Ding SF: Concurrent pheochromocytoma, ventricular tachycardia, left ventricular thrombus, and systemic embolization. Intern Med. 2009, 48 (12): 1015-1019. 10.2169/internalmedicine.48.2022.CrossRefPubMed Zhou W, Ding SF: Concurrent pheochromocytoma, ventricular tachycardia, left ventricular thrombus, and systemic embolization. Intern Med. 2009, 48 (12): 1015-1019. 10.2169/internalmedicine.48.2022.CrossRefPubMed
9.
go back to reference Zelinka T, Petrâak O, Strauch B, Holaj R, Kvasnicka J, Mazoch J, Pacâak K, Widimskây J: Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension. Neuroimmunomodulation. 2007, 14 (1): 57-64. 10.1159/000107289.CrossRefPubMed Zelinka T, Petrâak O, Strauch B, Holaj R, Kvasnicka J, Mazoch J, Pacâak K, Widimskây J: Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension. Neuroimmunomodulation. 2007, 14 (1): 57-64. 10.1159/000107289.CrossRefPubMed
10.
go back to reference Zwicker JI, Furie BC, Furie B: Cancer-associated thrombosis. Crit Rev Oncol Hematol. 2007, 62 (2): 126-136. 10.1016/j.critrevonc.2007.01.001.CrossRefPubMed Zwicker JI, Furie BC, Furie B: Cancer-associated thrombosis. Crit Rev Oncol Hematol. 2007, 62 (2): 126-136. 10.1016/j.critrevonc.2007.01.001.CrossRefPubMed
11.
go back to reference Jebara VA, Uva MS, Farge A, Acar C, Azizi M, Plouin PF, Corvol P, Chachques JC, Dervanian P, Fabiani JN: Cardiac pheochromocytomas. Ann Thorac Surg. 1992, 53 (2): 356-361. 10.1016/0003-4975(92)91354-C.CrossRefPubMed Jebara VA, Uva MS, Farge A, Acar C, Azizi M, Plouin PF, Corvol P, Chachques JC, Dervanian P, Fabiani JN: Cardiac pheochromocytomas. Ann Thorac Surg. 1992, 53 (2): 356-361. 10.1016/0003-4975(92)91354-C.CrossRefPubMed
12.
go back to reference Aravot DJ, Banner NR, Cantor AM, Theodoropoulos S, Yacoub MH: Location, localization and surgical treatment of cardiac pheochromocytoma. Am J Cardiol. 1992, 69 (3): 283-285. 10.1016/0002-9149(92)91324-W.CrossRefPubMed Aravot DJ, Banner NR, Cantor AM, Theodoropoulos S, Yacoub MH: Location, localization and surgical treatment of cardiac pheochromocytoma. Am J Cardiol. 1992, 69 (3): 283-285. 10.1016/0002-9149(92)91324-W.CrossRefPubMed
13.
go back to reference Danta G: Pre- and postoperative platelet adhesiveness in pheochromocytoma. Thromb Diath Haemorrh. 1970, 23 (1): 189-190.PubMed Danta G: Pre- and postoperative platelet adhesiveness in pheochromocytoma. Thromb Diath Haemorrh. 1970, 23 (1): 189-190.PubMed
14.
go back to reference Nakada K, Enami T, Kawada T, Hoson M, Wakisaka M, Mochizuki A, Kashimura T, Yamate N: Characterization of platelet activity in neuroblastoma. J Pediat Surg. 1994, 29 (5): 625-629. 10.1016/0022-3468(94)90727-7.CrossRefPubMed Nakada K, Enami T, Kawada T, Hoson M, Wakisaka M, Mochizuki A, Kashimura T, Yamate N: Characterization of platelet activity in neuroblastoma. J Pediat Surg. 1994, 29 (5): 625-629. 10.1016/0022-3468(94)90727-7.CrossRefPubMed
15.
go back to reference Gomes MP, Deitcher SR: Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004, 164 (18): 1965-1976. 10.1001/archinte.164.18.1965.CrossRefPubMed Gomes MP, Deitcher SR: Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004, 164 (18): 1965-1976. 10.1001/archinte.164.18.1965.CrossRefPubMed
16.
go back to reference Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM: Estrogens, progestogens and thrombosis. J Thromb Haemost. 2003, 1 (7): 1371-1380. 10.1046/j.1538-7836.2003.00264.x.CrossRefPubMed Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM: Estrogens, progestogens and thrombosis. J Thromb Haemost. 2003, 1 (7): 1371-1380. 10.1046/j.1538-7836.2003.00264.x.CrossRefPubMed
17.
go back to reference Tanis BC, Rosendaal FR: Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Semin Vasc Med. 2003, 3 (1): 69-84. 10.1055/s-2003-38334.CrossRefPubMed Tanis BC, Rosendaal FR: Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Semin Vasc Med. 2003, 3 (1): 69-84. 10.1055/s-2003-38334.CrossRefPubMed
18.
go back to reference Lidegaard O, Lokkegaard E, Svendsen AL, Agger C: Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009, 339: b2890-10.1136/bmj.b2890.CrossRefPubMedPubMedCentral Lidegaard O, Lokkegaard E, Svendsen AL, Agger C: Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009, 339: b2890-10.1136/bmj.b2890.CrossRefPubMedPubMedCentral
19.
go back to reference Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995, 274 (13): 1049-1057. 10.1001/jama.274.13.1049.CrossRefPubMed Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995, 274 (13): 1049-1057. 10.1001/jama.274.13.1049.CrossRefPubMed
20.
go back to reference den Heijer M: Hyperhomocysteinaemia as a risk factor for venous thrombosis: an update of the current evidence. Clin Chem Lab Med. 2003, 41 (11): 1404-1407. 10.1515/CCLM.2003.215.PubMed den Heijer M: Hyperhomocysteinaemia as a risk factor for venous thrombosis: an update of the current evidence. Clin Chem Lab Med. 2003, 41 (11): 1404-1407. 10.1515/CCLM.2003.215.PubMed
21.
go back to reference Eldibany MM, Caprini JA: Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007, 131 (6): 872-884.PubMed Eldibany MM, Caprini JA: Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007, 131 (6): 872-884.PubMed
22.
go back to reference Selhub J, D'Angelo A: Relationship between homocysteine and thrombotic disease. Am J Med Sci. 1998, 316 (2): 129-141. 10.1097/00000441-199808000-00008.PubMed Selhub J, D'Angelo A: Relationship between homocysteine and thrombotic disease. Am J Med Sci. 1998, 316 (2): 129-141. 10.1097/00000441-199808000-00008.PubMed
Metadata
Title
Pheochromocytoma presenting with arterial and intracardiac thrombus in a 47-year-old woman: a case report
Authors
Runhua Hou
Ann M Leathersich
Brenda Temke Ruud
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2011
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-5-310

Other articles of this Issue 1/2011

Journal of Medical Case Reports 1/2011 Go to the issue